Status:
RECRUITING
Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study
Lead Sponsor:
Mayo Clinic
Conditions:
Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of hu...
Detailed Description
PRIMARY OBJECTIVES: I. Prospectively determine the incidence of anogenital infection with high-risk HPV serotypes and HPV-associated anogenital lesions in female patients with newly diagnosed HPV(+)O...
Eligibility Criteria
Inclusion
- \* Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester
- Age ≥ 18
- Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC
- Patient has given permission to give his/her blood/saliva sample for research testing
- Ability to complete questionnaire(s) by themselves or with assistance
Exclusion
- \* HPV(-) OPSCC
- Unable to provide informed consent
- Unwilling to attend screening visit at Mayo Clinic site, if indicated
- Unwilling/unable to complete surveys electronically
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT06115772
Start Date
November 1 2022
End Date
November 1 2027
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905